Cat. #154781
Anti-CD20 [B20]
Cat. #: 154781
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: CD20
Class: Monoclonal
Application: ELISA ; FACS ; IP
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Netherlands Cancer Institute
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-CD20 [B20]
- Alternate name: B-lymphocyte antigen CD2
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 35 kDa
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; FACS ; IP
- Description: CD20 is expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity.
- Immunogen: Daudi cells (Burkitt lymphoma)
- Isotype: IgG1
- Myeloma used: Sp2/0-Ag14
Target Details
- Target: CD20
- Molecular weight: 35 kDa
- Target background: CD20 is expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity.
Applications
- Application: ELISA ; FACS ; IP
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Hooijberg et al. 1996. Hybridoma. 15(1):23-31. PMID: 9064283.
